Abstract:Background and Objectives Solid organ transplant surgeries including liver transplants constitute a substantial risk of bleeding complications and given frequent national blood shortages, supporting D‐negative transplant recipients with D‐negative red blood cell products perioperatively can be difficult for the transfusion services. This study was designed to compare the incidence of alloimmunization after D‐mismatched red cell transfusions between patients with and without a history of solid organ transplant at a single tertiary care hospital. The patients undergoing solid organ transplants are on strong immunosuppressive regimens perioperatively to help reduce the risk of rejection. We hypothesized that the use of these immunosuppressive agents makes these patients very less likely to mount an immune response and form anti‐D antibodies when exposed to the D‐positive red blood cell products perioperatively. Study Design and Methods At our center, D‐negative patients who received ≥1 unit of D‐positive red blood cell products were identified using historical transfusion records. Antibody testing results were examined to determine the incidence of the formation of anti‐D and any other red cell alloantibodies after transfusion and these results were compared between patients with and without a history of solid organ transplant. Results We were able to identify a total of 22 patients over 10 years with D‐negative phenotype who had undergone a solid organ transplant and had received D‐positive red blood cell products during the transplant surgeries. We also identified a second group of 54 patients with D‐negative phenotype who had received D‐positive red blood cell products for other indications including medical and surgical. A comparison of the data showed no new anti‐D formation among patients with a history of D mismatched transfusion during solid organ transplant surgeries. Conclusion Among our limited study population, we observed a very low likelihood of D alloimmunization among solid organ transplant recipients. A larger, prospective study could help further evaluate the need for prophylactic D matching for red cell transfusions during solid organ transplant surgeries.

RhD‐negative red blood cells can be saved during liver transplantation in RhD‐negative patients due to low risk of alloimmunization against RhD

Transfusing selected RhD negative patients with RhD positive packed red cell concentrates resulted in lower frequency of anti‐D development and saved almost two thousand RhD negative concentrates during 5 years

Clinical Significance of Screening of Rh-negative Blood Group and Detection of Irregular Antibody

Receipt of RhD‐positive whole blood for life‐threatening bleeding in female children: A survey in alloimmunized mothers regarding minimum acceptable survival benefit relative to risk of maternal alloimmunization to anti‐D

Red blood cell alloimmunization in transfused patients with myelodysplastic syndromes: a retrospective study from northern China

Incidence of formation of anti‐D between patients with and without a history of solid organ transplant

Timing of RhD-positive red blood cell administration is associated with D-alloimmunization in injured patients

Another piece of the hemolytic disease of the fetus and newborn puzzle after RhD-positive transfusion in trauma resuscitation: the proportion of pregnant women who produce high titer anti-D

Not as "D"eadly as once thought - the risk of D-alloimmunization and hemolytic disease of the fetus and newborn following RhD-positive transfusion in trauma

Transfusion support during childbirth for a woman with anti-U and the RHD*weak D type 4.0 allele

Blood Management in a Liver Transplant Recipient with Kidd (Jka) and Rhesus (D) Antibodies: A Case Report

Risk of a false‐positive HLA crossmatch after administration of Rh 0 (D) immune globulin

RhD-positive red blood cell allocation practice to RhD-negative patients before and during the COVID-19 pandemic

Anti‐D immunization after D positive platelet transfusions in D negative recipients: A systematic review and meta‐analysis

Survey of policies at US hospitals on the selection of RhD type of low‐titer O whole blood for use in trauma resuscitation

Analysis of Rhesus (Rh) Antigen Distributions in Donors and Multi-transfused Patients for Phenotype-Matched Transfusion

Donor/recipient Rh-mismatched allogeneic hematopoietic stem cell transplantation: transfusion strategy and allo-immunization to red blood cell antigens

Low titer group O whole blood and risk of RhD alloimmunization: Rationale for use in Finland

Management of Red Cell Alloimmunization in Pregnancy

Rh immune globulin immunoprophylaxis after RhD‐positive red cell exposure in RhD‐negative patients via transfusion: A survey of practices

Alloimmunization Induced by RhD Antigens During Apheresis Platelet Concentrates Transfusion and Its Clinical Application